Among the T2D-associated methylation sites in our study, 2507 were in regions marked as active promoters, 4121 in active enhancers, and 1305 in strong CTCF regions (Fig. 4d, Supplementary Data 12). The gene discussed is CTCF; the disease is type 2 diabetes mellitus.